Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| K-GHEALTH | +8.68% | +2.43% | +4.12% | +9.71% | +7.39% | +15.70% | +14.91% | +23.85% | −1.08% | +45.66% | +95.43% | +51.40% |
| BCARE | +14.91% | +1.99% | +5.09% | +8.23% | +8.14% | +17.30% | +23.16% | +33.14% | +7.17% | +55.95% | +94.75% | +73.10% |
| ES-HEALTHCARERMF | +9.03% | +2.65% | +4.99% | +6.96% | +4.20% | +13.51% | +18.15% | +38.33% | +14.00% | +60.67% | +105.72% | +59.48% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| K-GHEALTH | ES-HEALTHCARERMF | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.17% | 9.38% |
 Johnson & Johnson | 6.43% | 7.59% |
 ABBVIE | 7.45% | 4.81% |
 AstraZeneca | 4.19% | 3.62% |
 Unitedhealth Group | 3.37% | 4.17% |
 Thermo Fisher | 4.70% | 3.27% |
 Novartis | 4.59% | 2.67% |
 Merck & | 5.41% | 2.29% |
| Only in K-GHEALTH | ||
 Abbott Laboratories | 2.96% | N/A |
 Danaher | 2.96% | N/A |
| Only in ES-HEALTHCARERMF | ||
 Roche | N/A | 2.62% |
 argenx | N/A | 2.39% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| BCARE | +14.91% | 15.93% | 0.94 |
| K-GHEALTH | +8.68% | 15.48% | 0.56 |
| ES-HEALTHCARERMF | +9.03% | 16.68% | 0.54 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | K-GHEALTH | BCARE | ES-HEALTHCARERMF |
|---|---|---|---|
Fund details | |||
| Fund size | 3,130 million | 4,712 million | 356 million |
| Inception date | 26 Nov 2014 | 29 Aug 2007 | 7 Jul 2015 |
| Master fund | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | Wellington Global Health Care Equity Fund | กองทุน Janus Henderson Global Life Sciences Fund |
| Dividend policy | Pays | Does not pay | Does not pay |
Risk and currency hedging | |||
| Risk level | 6 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 93.16% | 47.41% | 96.33% |
Minimum purchase and redemption | |||
| First purchase | 500 THB | 500 THB | 1 THB |
| Subsequent purchase | 500 THB | 500 THB | 1 THB |
| Redemption (amount) | 500 THB | No minimum | 1 THB |
| Redemption (units) | No minimum | No minimum | 1 units |
| Balance (amount) | 50 THB | No minimum | No minimum |
| Balance (units) | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | |||
| Buy before | 15:30 | 15:30 | 15:30 |
| Redeem before | 14:30 | 15:30 | 15:30 |
| Redemption paid | T+4 | T+4 | T+4 |
